Title : Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.

Pub. Date : 2010 Jul

PMID : 20172040






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan. Idarubicin nucleophosmin 1 Homo sapiens
2 In this study we describe treatment results from a series of 19 patients with NPM+/FLT3- autografted in first complete remission (CR) after conditioning with a regimen, named BuI, based on high-dose continuous infusion of idarubicin and Busulfan. Idarubicin nucleophosmin 1 Homo sapiens